Frailty as a predictor of delayed initiation of adjuvant chemotherapy in patients with ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

other Versions

You are currently viewing an earlier version of this article (January 03, 2023).
View the most recent version of this article

Original research

Frailty as a predictor of delayed initiation of adjuvant chemotherapy in patients with ovarian cancer

Online download statistics by month:

Online download statistics by month: November 2022 to April 2024

	Abstract	Full	Pdf
Nov 2022	245	8	2
Dec 2022	485	22	11
Jan 2023	444	13	11
Feb 2023	210	10	8
Mar 2023	151	3	4
Apr 2023	177	4	3
May 2023	167	3	4
Jun 2023	38	2	1
Jul 2023	55	2	3
Aug 2023	74	2	3
Sep 2023	57	1	0
Oct 2023	62	3	3
Nov 2023	183	4	5
Dec 2023	89	2	4
Jan 2024	130	3	3
Feb 2024	158	2	6
Mar 2024	65	2	0
Apr 2024	64	1	1
Total	2854	87	72